YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Merck Shares Fall After Q4 Reports


February 5, 2013 | Merck has been downgraded by analysts due to struggles with Vytorin and Zocor. Q4 results announced last week raised questions about the drugs success and led to a 2.3% fall in share places. Philly.com
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.